RNA-seq profiling of NSCLC cell lines exposed to the PARP inhibitor talazoparib.
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/ERP112503
下载链接
链接失效反馈官方服务：
资源简介：
An isogenic model of ERCC1-deficiency derived from the A549 NSCLC cell line was used for this study; this model consists of an ERCC1-wildtype parental cell line and an ERCC1-knockout cell line that was generated by zinc-finger targeting of ERCC1 gene. Both cell lines were exposed to the PARPi talazoparib or DMSO (vehicle) for 48h in culture. For each condition, RNA was extracted from cells and subsequently sequenced on a HiSeq 2500 platform (Illumina).
创建时间：
2020-10-19
